IGF1R and colorectal carcinoma: In addition, Kaplan–Meier analysis exhibited that CRC patients who had a positive expression of ACLY or IGF1R exhibited higher recurrence rate and lower overall survival times than those who had a negative expression of ACLY or IGF1R in both cohorts (Fig. 5D, E).